The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment

BACKGROUND: Assessment of Ki67 by immunohistochemistry (IHC) has limited utility in clinical practice owing to analytical validity issues. According to International Ki67 Working Group (IKWG) guidelines, treatment should be guided by a prognostic test in patients expressing intermediate Ki67 range,...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshwaraiah, Mallikarjuna Siraganahalli, Gunda, Aparna, Kanakasetty, Govind Babu, Bakre, Manjiri M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315758/
https://www.ncbi.nlm.nih.gov/pubmed/37245224
http://dx.doi.org/10.1002/cam4.6032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315758/
https://www.ncbi.nlm.nih.gov/pubmed/37245224
http://dx.doi.org/10.1002/cam4.6032

Ejemplares similares